eMedicine Specialties > Pediatrics: Cardiac Disease and Critical Care Medicine > Critical Care
Dehydration: Treatment & Medication
Updated: Nov 3, 2009
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Treatment
Medical Care
Medications such as loperamide, opiates, anticholinergics, bismuth subsalicylate, and adsorbents are not recommended in dehydration because of questionable efficacy and potential adverse effects.
Oral rehydration solutions
During gastroenteritis, the intestinal mucosa retains absorptive capacity. Sodium and glucose in the correct proportions can be passively cotransported with fluid from the gut lumen into the circulation. Rapid oral rehydration with the appropriate solution has been shown to be as effective as intravenous fluid therapy in restoring intravascular volume and correcting acidosis.
Table 3. Composition of Appropriate Oral Rehydration Solutions
Open table in new window
Table
| Solution | Carbohydrate (g/dL) | Sodium (mEq/L) | Potassium (mEq/L) | Base (mEq/L) | Osmolality |
|---|---|---|---|---|---|
| Pedialyte | 2.5 | 45 | 20 | 30 | 250 |
| Infalyte | 3 | 50 | 25 | 30 | 200 |
| Rehydralyte | 2.5 | 75 | 20 | 30 | 310 |
| WHO/UNICEF* | 2 | 90 | 20 | 30 | 310 |
| Solution | Carbohydrate (g/dL) | Sodium (mEq/L) | Potassium (mEq/L) | Base (mEq/L) | Osmolality |
|---|---|---|---|---|---|
| Pedialyte | 2.5 | 45 | 20 | 30 | 250 |
| Infalyte | 3 | 50 | 25 | 30 | 200 |
| Rehydralyte | 2.5 | 75 | 20 | 30 | 310 |
| WHO/UNICEF* | 2 | 90 | 20 | 30 | 310 |
* World Health Organization/United Nations Children's Fund
All of the commercially available rehydration fluids are acceptable for oral rehydration therapy (ORT). They contain 2-3 g/dL of glucose, 45-90 mEq/L of sodium, 30 mEq/L of base, and 20-25 mEq/L of potassium. Osmolality is 200-310 mOsm/L.
Table 4. Composition of Inappropriate Oral Rehydration Solutions
Open table in new window
Table
| Solution | Carbohydrate (g/dL) | Sodium (mEq/L) | Potassium (mEq/L) | Base (mEq/L) | Osmolality |
|---|---|---|---|---|---|
| Apple juice | 12 | 0.4 | 26 | 0 | 700 |
| Ginger ale | 9 | 3.5 | 0.1 | 3.6 | 565 |
| Milk | 4.9 | 22 | 36 | 30 | 260 |
| Chicken broth | 0 | 2 | 3 | 3 | 330 |
| Solution | Carbohydrate (g/dL) | Sodium (mEq/L) | Potassium (mEq/L) | Base (mEq/L) | Osmolality |
|---|---|---|---|---|---|
| Apple juice | 12 | 0.4 | 26 | 0 | 700 |
| Ginger ale | 9 | 3.5 | 0.1 | 3.6 | 565 |
| Milk | 4.9 | 22 | 36 | 30 | 260 |
| Chicken broth | 0 | 2 | 3 | 3 | 330 |
Traditional clear fluids are not appropriate for ORT. Many contain excessive concentrations of CHO and low concentrations of sodium. The inappropriate glucose-to-sodium ratio impairs water absorption, and the large osmotic load creates an osmotic diarrhea, further worsening the degree of dehydration.
- ORT for mild or moderate dehydration
- Mild or moderate dehydration can usually be treated very effectively with ORT.6
- Vomiting is generally not a contraindication to ORT. If evidence of bowel obstruction, ileus, or acute abdomen is noted, then intravenous rehydration is indicated.
- Calculate fluid deficit. Physical findings consistent with mild dehydration suggest a fluid deficit of 5% of body weight in infants and 3% in children. Moderate dehydration occurs with a fluid deficit of 5-10% in infants and 3-6% in children (see Table 1 and Table 2). The fluid deficit should be replaced over 4 hours.
- The oral rehydration solution should be administered in small volumes very frequently to minimize gastric distention and reflex vomiting. Generally, 5 mL of oral rehydration solution every minute is well tolerated. Hourly intake and output should be recorded by the caregiver. As the child becomes rehydrated, vomiting often decreases and larger fluid volumes may be used.
- If vomiting persists, infusion of oral rehydration solution via a nasogastric tube may be temporarily used to achieve rehydration. Intravenous fluid administration (20-30 mL/kg of isotonic sodium chloride 0.9% solution over 1-2 h) may also be used until oral rehydration is tolerated. According to a Cochrane systematic review, for every 25 children treated with ORT for dehydration, one fails and requires intravenous therapy.7
- Replace ongoing losses from stools and emesis (estimate volume and replace) in addition to replacing the calculated fluid deficit.
- An age appropriate diet may be started as soon as the child is able to tolerate oral intake.
- Severe dehydration
- Laboratory evaluation and intravenous rehydration are required. The underlying cause of the dehydration must be determined and appropriately treated.
- Phase 1 focuses on emergency management. Severe dehydration is characterized by a state of hypovolemic shock requiring rapid treatment. Initial management includes placement of an intravenous or intraosseous line and rapid administration of 20 mL/kg of an isotonic crystalloid (eg, lactated Ringer solution, 0.9% sodium chloride). Additional fluid boluses may be required depending on the severity of the dehydration. The child should be frequently reassessed to determine the response to treatment. As intravascular volume is replenished, tachycardia, capillary refill, urine output, and mental status all should improve. If improvement is not observed after 60 mL/kg of fluid administration, other etiologies of shock (eg, cardiac, anaphylactic, septic) should be considered. Hemodynamic monitoring and inotropic support may be indicated.
- Phase 2 focuses on deficit replacement, provision of maintenance fluids, and replacement of ongoing losses. Maintenance fluid requirements are equal to measured fluid losses (urine, stool) plus insensible fluid losses. Normal insensible fluid loss is approximately 400-500 mL/m2 body surface area and may be increased by factors such as fever and tachypnea. Alternatively, daily fluid requirements may be roughly estimated as follows:
- Less than 10 kg = 100 mL/kg
- 10-20 kg = 1000 + 50 mL/kg for each kg over 10 kg
- Greater than 20 kg = 1500 + 20 mL/kg for each kg over 20 kg
- Severe dehydration by clinical examination suggests a fluid deficit of 10-15% of body weight in infants and 6-9% of body weight in older children. The daily maintenance fluid is added to the fluid deficit. In general, the recommended administration is one half of this volume administered over 8 hours and administration of the remainder over the following 16 hours. Continued losses (eg, emesis, diarrhea) must be promptly replaced.
- If the child is isonatremic (130-150 mEq/L), the sodium deficit incurred can generally be corrected by administering the fluid deficit plus maintenance as 5% dextrose in 0.45-0.9% sodium chloride. Potassium (20 mEq/L potassium chloride) may be added to maintenance fluid once urine output is established and serum potassium levels are within a safe range.
- An alternative approach to the deficit therapy approach is rapid replacement therapy. With this approach, a child with severe isonatremic dehydration is administered 20-40 mL/kg of isotonic sodium chloride solution or lactated Ringer solution over 15-60 minutes. As perfusion is restored, the child improves and is able to tolerate an oral rehydration solution for the remainder of his rehydration. This approach is not appropriate for hypernatremic or hyponatremic dehydration.
- Hyponatremic dehydration
- Phase 1 management of hyponatremic dehydration is identical to that of isonatremic dehydration. Rapid volume expansion with 20 mL/kg of isotonic (0.9%) sodium chloride solution or lactated Ringer solution should be administered and repeated until perfusion is restored.
- Severe hyponatremia (<130 mEq/L) indicates additional sodium loss. In phase 2 management, rehydration is calculated as for isonatremic dehydration. The additional sodium deficit must be calculated and added to the rehydration fluids. The deficit may be calculated to restore the sodium to 130 mEq/L and administered over 24 hours.
- Sodium deficit = (sodium desired - sodium actual) X volume of distribution X weight (kg)
- Example: Sodium = 123, weight = 10 kg, assumed volume of distribution of 0.6; Sodium deficit = (130-123) X 0.6 X 10 kg = 42 mEq sodium
- A simplified approach is to use 5% dextrose in 0.9% sodium chloride as the replacement fluid. The sodium is closely monitored, and the amount of sodium in the fluid is adjusted to maintain a slow correction (<0.5 mEq/L/h).
- Frequently reassessing the serum sodium level during correction is imperative. Rapid correction of chronic hyponatremia (>2 mEq/L/h) has been associated with central pontine myelinolysis. Rapid partial correction of symptomatic hyponatremia has not been associated with adverse effects. Therefore, if the child is symptomatic (seizures), a more rapid partial correction is indicated. Hypertonic (3%) sodium chloride solution (0.5 mEq/mL) may be used for rapid partial correction of symptomatic hyponatremia. A bolus dose of 4 mL/kg raises the serum sodium by 3-4 mEq/L.
- Hypernatremic dehydration
- Phase 1 management of hypernatremic dehydration is identical to that of isonatremic dehydration. Rapid volume expansion with 20 mL/kg of isotonic sodium chloride solution or lactated Ringer solution should be administered and repeated until perfusion is restored.
- Varied regimens may be successfully followed to achieve correction of severe hypernatremia (>150 mEq/L). In phase 2 management, the most important goal is to reestablish intravascular volume and return serum sodium levels toward the reference range by not more than 10 mEq/L/24h. Rapid correction of hypernatremic dehydration can have disastrous neurologic consequences, including cerebral edema and death.
- The most cautious approach is to plan a slow correction of the fluid deficit over 48 hours. Following adequate intravascular volume expansion, rehydration fluids should be initiated with 5% dextrose in 0.9% sodium chloride. Serum sodium levels should be assessed every 4 hours. If the sodium has decreased by less than 0.5 mEq/L/h, then the sodium content of the rehydration fluid is decreased. This allows for a slow controlled correction of the hypernatremic state.
- Hyperglycemia and hypocalcemia are sometimes associated with hypernatremic dehydration. Serum glucose and calcium levels should be closely monitored.
- Pharmacologic management
- Antidiarrheal agents are not recommended because of a high incidence of side effects including lethargy, respiratory depression, and coma.
- Routine empiric antibiotics should be avoided and may worsen some specific diarrheal disease states (eg, hemolytic-uremic syndrome, Clostridium difficile).
- Over-the-counter antiemetics are not recommended due to side effects including drowsiness and impaired oral rehydration.
- In an emergency department study, ondansetron has been shown to decrease likelihood of vomiting, increase oral intake, and decrease emergency department length of stay but has not shown significant effects on hospitalization rates or long-term outcomes.8
- Dimenhydrinate, although used in Europe and Canada, has not been found to improve oral rehydration.9
Diet
- Children with dehydration from gastroenteritis have decreased duration of diarrhea when feedings are started as soon as the patient is able to tolerate oral intake.
- Diluting milk or formula is not indicated. Breast-feeding should be resumed as soon as possible.
- Foods that contain complex carbohydrates (eg, rice, wheat, potatoes, bread, cereals), lean meats, fruits, and vegetables are encouraged. Fatty foods and simple carbohydrates should be avoided.
Medication
Antiemetic, Serotonin Antagonist
In a recent emergency department study, ondansetron was shown to decrease likelihood of vomiting, increase oral intake, and decrease emergency department length of stay.8
Ondansetron (Zofran)
Selective 5-HT3-receptor antagonist that blocks serotonin both peripherally and centrally. Prevents nausea and vomiting associated with emetogenic cancer chemotherapy (eg, high-dose cisplatin), and complete body radiotherapy.
Adult
8 mg PO q1-2h for 3 doses
Alternatively, 0.15 mg/kg IV q8h for 3 doses or 32 mg IV once
Pediatric
Orally dissolving tablets:
8-15 kg: 2 mg as a single dose
15-30 kg: 4 mg as a single dose
>30 kg: 8 mg as a single dose
Although there is potential for cytochrome P-450 inducers (eg, barbiturates, rifampin, carbamazepine, phenytoin) to change half-life and clearance of ondansetron, dosage adjustment is not usually required
Documented hypersensitivity
Pregnancy
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Precautions
May cause headache
More on Dehydration |
| Overview: Dehydration |
| Differential Diagnoses & Workup: Dehydration |
 Treatment & Medication: Dehydration |
| Follow-up: Dehydration |
| References |
| « Previous Page | Next Page » |
References
[Guideline] Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics. Sep 2008;122(3):545-9. [Medline].
Steiner MJ, DeWalt DA, Byerley JS. Is this child dehydrated?. JAMA. Jun 9 2004;291(22):2746-54. [Medline].
Colletti JE, Brown KM, Sharieff GQ, Barata IA, Ishimine P. The Management of Children with Gastroenteritis and Dehydration in the Emergency Department. J Emerg Med. Apr 2 2009;[Medline].
Parkin PC, Macarthur C, Khambalia A, Goldman RD, Friedman JN. Clinical and Laboratory Assessment of Dehydration Severity in Children With Acute Gastroenteritis. Clin Pediatr (Phila). Jun 1 2009;[Medline].
Steiner MJ, Nager AL, Wang VJ. Urine specific gravity and other urinary indices: inaccurate tests for dehydration. Pediatr Emerg Care. May 2007;23(5):298-303. [Medline].
Atherly-John YC, Cunningham SJ, Crain EF. A randomized trial of oral vs intravenous rehydration in a pediatric emergency department. Arch Pediatr Adolesc Med. Dec 2002;156(12):1240-3. [Medline].
Hartling L, Bellemare S, Wiebe N, Russell K, Klassen TP, Craig W. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev. Jul 19 2006;3:CD004390. [Medline].
[Best Evidence] Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. Apr 20 2006;354(16):1698-705. [Medline].
Uhlig U, Pfeil N, Gelbrich G, et al. Dimenhydrinate in children with infectious gastroenteritis: a prospective, RCT. Pediatrics. Oct 2009;124(4):e622-32. [Medline].
Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. May 18 2000;342(20):1493-9. [Medline].
Bellemare S, Hartling L, Wiebe N, et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med. Apr 15 2004;2:11. [Medline].
Bender BJ, Ozuah PO, Crain EF. Oral rehydration therapy: is anyone drinking?. Pediatr Emerg Care. Sep 2007;23(9):624-6. [Medline].
Bhatnagar S, Bahl R, Sharma PK, et al. Zinc with oral rehydration therapy reduces stool output and duration of diarrhea in hospitalized children: a randomized controlled trial. J Pediatr Gastroenterol Nutr. Jan 2004;38(1):34-40. [Medline].
Choice Study Group. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics. Apr 2001;107(4):613-8. [Medline].
Dale J. Oral rehydration solutions in the management of acute gastroenteritis among children. J Pediatr Health Care. Jul-Aug 2004;18(4):211-2. [Medline].
Duggan C, Fontaine O, Pierce NF, et al. Scientific rationale for a change in the composition of oral rehydration solution. JAMA. Jun 2 2004;291(21):2628-31. [Medline].
Duggan C, Refat M, Hashem M, et al. How valid are clinical signs of dehydration in infants?. J Pediatr Gastroenterol Nutr. Jan 1996;22(1):56-61. [Medline].
Duke T, Molyneux EM. Intravenous fluids for seriously ill children: time to reconsider. Lancet. Oct 18 2003;362(9392):1320-3. [Medline].
Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med. May 2004;158(5):483-90. [Medline].
Gorelick MH, Shaw, KN, Murphy, KO. Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics. 1997;May;(5):99:E6. [Medline].
Holliday M. The evolution of therapy for dehydration: should deficit therapy still be taught?. Pediatrics. Aug 1996;98(2 Pt 1):171-7. [Medline].
Holliday MA, Friedman AL, Segar WE, et al. Acute hospital-induced hyponatremia in children: a physiologic approach. J Pediatr. Nov 2004;145(5):584-7. [Medline].
Holliday MA, Friedman AL, Wassner SJ. Extracellular fluid restoration in dehydration: a critique of rapid versus slow. Pediatr Nephrol. May 1999;(4):292-7. [Medline].
Hoorn EJ, Geary D, Robb M, et al. Acute hyponatremia related to intravenous fluid administration in hospitalized children: an observational study. Pediatrics. May 2004;113(5):1279-84. [Medline].
King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. Nov 21 2003;52(RR-16):1-16. [Medline].
Miyasaka K, Shimizu N, Kojima J. Recent trends in pediatric fluid therapy. Methods Find Exp Clin Pharmacol. May 2004;26(4):287-94. [Medline].
Moritz ML, Ayus JC. Preventing neurological complications from dysnatremias in children. Pediatr Nephrol. Aug 4 2005;[Medline].
Moritz ML, Ayus JC. Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics. Feb 2003;111(2):227-30. [Medline].
Moritz ML, Manole MD, Bogen DL, Ayus JC. Breastfeeding-associated hypernatremia: are we missing the diagnosis?. Pediatrics. Sep 2005;116(3):e343-7. [Medline].
Murphy C, Hahn S, Volmink J. Reduced osmolarity oral rehydration solution for treating cholera. Cochrane Database Syst Rev. 2004;CD003754. [Medline].
Nager AL, Wang VJ. Comparison of nasogastric and intravenous methods of rehydration in pediatric patients with acute dehydration. Pediatrics. Apr 2002;109(4):566-72. [Medline].
Nalin DR, Hirschhorn N, Greenough W, et al. Clinical concerns about reduced-osmolarity oral rehydration solution. JAMA. Jun 2 2004;291(21):2632-5. [Medline].
Ozuah PO, Avner JR, Stein RE. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics. Feb 2002;109(2):259-61. [Medline].
Phin SJ, McCaskill ME, Browne GJ, Lam LT. Clinical pathway using rapid rehydration for children with gastroenteritis. J Paediatr Child Health. Jul 2003;39(5):343-8. [Medline].
Playfor SD. Hypotonic intravenous solutions in children. Expert Opin Drug Saf. Jan 2004;3(1):67-73. [Medline].
Reid SR, Bonadio WA. Outpatient rapid intravenous rehydration to correct dehydration and resolve vomiting in children with acute gastroenteritis. Ann Emerg Med. Sep 1996;28(3):318-23. [Medline].
Santosham M, Keenan EM, Tulloch J, et al. Oral rehydration therapy for diarrhea: an example of reverse transfer of technology. Pediatrics. Nov 1997;100(5):E10. [Medline].
Sarnaik AP, Meert K, Hackbarth R, Fleischmann L. Management of hyponatremic seizures in children with hypertonic saline: a safe and effective strategy. Crit Care Med. 1991;Jun;19(6):758-62. [Medline].
[Best Evidence] Spandorfer PR, Alessandrini EA, Joffe MD, et al. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics. Feb 2005;115(2):295-301. [Medline].
Wathen JE, MacKenzie T, Bothner JP. Usefulness of the serum electrolyte panel in the management of pediatric dehydration treated with intravenously administered fluids. Pediatrics. Nov 2004;114(5):1227-34. [Medline].
Further Reading
Keywords
dehydration, negative fluid balance, diarrheal illness, diarrhea, isonatremic dehydration, hypernatremic dehydration, hyponatremic dehydration, end organ failure, cerebral edema, gastroenteritis, cystic fibrosis, diabetes mellitus, treatment, diagnosis
